EIF3S2 Antibody (N-term) Blocking Peptide

Produktübersicht

• Artikelname: EIF3S2 Antibody (N-term) Blocking Peptide
• Artikelnummer: ABT-BP8547A
• Hersteller Artikelnummer: BP8547a
• Alternativnummer: ABT-BP8547A-500UG
• Hersteller: Abcepta
• Kategorie: Proteine/Peptide
• Alternative Synonym: Eukaryotic translation initiation factor 3 subunit I {ECO:0000255|HAMAP-Rule:MF_03008}, eIF3i {ECO:0000255|HAMAP-Rule:MF_03008}, Eukaryotic translation initiation factor 3 subunit 2 {ECO:0000255|HAMAP-Rule:MF_03008}, TGF-beta receptor-interacting protein 1, TRIP-1, eIF-3-beta {ECO:0000255|HAMAP-Rule:MF_03008}, eIF3 p36 {ECO:0000255|HAMAP-Rule:MF_03008}, EIF3I {ECO:0000255|HAMAP-Rule:MF_03008}

Produktbeschreibung

EIF3S2 is the largest of the EIFs. It consists of at least 10 nonidentical subunits in mammals. In S. cerevisiae the p39 subunit contains WD repeats, these are thought to mediate protein-protein interactions. The p39 protein appears to be essential for maintaining the integrity of the yeast EIF3 complex. The mammalian EIF3-p36 subunit is homologous to yeast p39.

Produkteigenschaften

• NCBI: 8668
• UniProt: Q13347
• Formulierung: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
• Target-Kategorie: The synthetic peptide sequence used to generate the antibody AP8547a was selected from the N-term region of human EIF3S2. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.